Amyloidosis: open trials in Argentina

11 open trials have a site in Argentina. Registry data; only the trial team decides who can take part.

NCT06128629
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Trial Treatment · Phase 3 · Intellia Therapeutics
Fundacion Favalro, Buenos Aires · ICBA, Buenos Aires · Hospital Italiano de Buenos Aires, Buenos Aires · Hospital Italiano de Buenos Aires, Ciudad Autonoma de Buenos Aire · Fundacion Favaloro, Ciudad Autonoma de Buenos Aire · Hospital Privado de Rosario, Rosario
Registry updated 2026-11-04
NCT06679946
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Trial Treatment · Phase 3 · Alnylam Pharmaceuticals
Buenos Aires · Córdoba · Rosario
Registry updated 2026-10-21
NCT07207811
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Trial Treatment · Phase 3 · Novo Nordisk A/S
Nexo salud, Buenos Aires · Icba - Instituto Cardiovascular De Buenos Aires, Buenos Aires · Centro Medico dr Besada, Buenos Aires · Hospital Italiano de Buenos Aires (HIBA), Buenos Aires · Centro Medico Dra Laura Maffei Investigacion Clinica Aplicada, Caba · Hospital Privado Centro Medico de Cordoba S.A, Córdoba · Instituto de Cardiologia de Corrientes Juana Fca. Cabral, Corrientes · DIM Clínica Privada, Ramos Mejía · Centro de Investigaciones Clinicas del Litoral, Santa Fe
Registry updated 2026-10-21
NCT07052903
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Trial Treatment · Phase 3 · Alnylam Pharmaceuticals
Buenos Aires · Córdoba · Rosario
Registry updated 2026-10-20
NCT07223203
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Trial Treatment · Phase 3 · Alnylam Pharmaceuticals
Belgrano · Rosario
Registry updated 2026-10-08
NCT07789483
An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
Trial Treatment · Phase 3 · Alexion Pharmaceuticals, Inc.
Buenos Aires · CABA · Ciudad de Buenos Aires · Córdoba
Registry updated 2026-08-28
NCT06563895
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Trial Treatment · Phase 3 · Eidos Therapeutics, a BridgeBio company
Hospital Britanico de Buenos Aires, Buenos Aires · Hospital Italiano de Buenos Aires, Buenos Aires · ICBA - Instituto Cardiovascular de Buenos Aires S.A., CABA
Registry updated 2026-08-04
NCT05667493
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Trial Treatment · Phase 3 · Ionis Pharmaceuticals, Inc.
Instituto Cardiovascular de Buenos Aires, Buenos Aires · Hospital Italiano de Buenos Aires, Buenos Aires
Registry updated 2026-04-17
NCT07124377
Phenotypic Manifestations of Hereditary ATTR Amyloidosis
Research · Hospital 9 de Julio de Las Breñas
Hospital las Breñas 9 de Julio, Charata · Hosptial Las Breñas, Charata
Registry updated 2026-04-02
NCT07213297
Comprehensive Program for Hereditary Transthyretin Amyloidosis
Research · Hospital de Alta Complejidad en Red
Hospital Cuenca Alta de Cañuelas, Canuelas
Registry updated 2026-03-24
NCT06573723
Institutional Registry of Rare Diseases
Research · Hospital Italiano de Buenos Aires
Hospital Italiano de Buenos Aires, Buenos Aires
Registry updated 2026-01-14

All Amyloidosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error